Chainlink vs Enzyme — how do they compare? Chainlink trades at Rp153,900 (market cap Rp115,23T, Rp5,31T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Chainlink is far larger — about 859091.9× Enzyme's market cap, and Chainlink's supply is capped (748,1M / 1B LINK (75%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chainlink for 62 Days and Enzyme for 28 Days on average.
| LINK | MLN | |
|---|---|---|
Market Cap | Rp115,23T | Rp134,13M |
Volume (24h) | Rp5,31T | Rp104,56M |
Circulating Supply | 748,1M / 1B LINK (75%) | 3,3M MLN |
Typical Hold Time | 62 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Chainlink (LINK) is currently trading at Rp153,763 with a market cap of Rp115.23T, showing bullish technical signals with strong moving average support. The token trades near its pivot point of Rp153,486 with key resistance at Rp157,254. Recent positive sentiment stems from former Chainlink executive Taylor Lindman joining the SEC's Crypto Task Force, potentially benefiting crypto regulatory clarity. The circulating supply of 748.1 million LINK represents 75% of total supply, with average hold time of 62 days indicating moderate investor confidence.
Overall outlook remains cautiously optimistic with technical momentum supporting upward potential, though RSI levels suggest overbought conditions. Key opportunities include Chainlink's crucial role in blockchain-oracle services and potential regulatory tailwinds. Major risks include high volatility near resistance levels and broader crypto market sensitivity. Investors should monitor support at Rp150,487 for potential entry points.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →